Clinical Trial Update: Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab with radiation therapy for locally advanced, unresectable pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED